X
20
Dong Bang Future Tech & Life Co., Ltd. Hwaseong-si Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Ketoprofen, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2008-120 - Rev 01
This Chemical Type CEP, issued on December 19, 2016, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 922 associated with this CEP further emphasizes